维普中文期刊产品整合服务
1385篇 您的检索式:作者名="Koch R"
    题名 作者 年代 出处 被引量
1Development of minimally invasive techniques for management of medically-complicated obesity显示文摘The field of bariatric surgery has been rapidly growing and evolving over the past several decades. During the period that obesity has become a worldwide epidemic, new interventions have been developed to combat this complex disorder. The development of new laparoscopic and minimally invasive treatments for medically-complicated obesity has made it essential that gastrointestinal physicians obtain a thorough understanding of past developments and possible future directions in bariatrics. New laparoscopic advancements provide patients and practitioners with a variety of options that have an improved safety profile and better efficacy without open, invasive surgery. The mechanisms of weight loss after bariatric surgery are complex and may in part be related to altered release of regulatory peptide hormones from the gut. Endoscopic techniques designed to mimic the effects of bariatric surgery and endolumenal inter-ventions performed entirely through the gastrointestinal tract offer potential advantages. Several of these new techniques have demonstrated promising, preliminary results. We outline herein historical and current trends in the development of bariatric surgery and its transition to safer and more minimally invasive procedures designed to induce weight loss.Farzin Rashti Ekta Gupta Suzan Ebrahimi Timothy R Shope Timothy R Koch Christopher J Gostout 2014World Journal of Gastroenterology2014,20,37:4
2Dysphagia after vertical sleeve gastrectomy: Evaluation of risk factors and assessment of endoscopic intervention显示文摘AIM To evaluate the risks of medical conditions, evaluate gastric sleeve narrowing, and assess hydrostatic balloon dilatation to treat dysphagia after vertical sleeve gastrectomy(VSG).METHODS VSG is being performed more frequently worldwide as a treatment for medically-complicated obesity, and dysphagia is common post-operatively. We hypothesize that post-operative dysphagia is related to underlying medical conditions or narrowing of the gastric sleeve. This is a retrospective, single institution study of consecutive patients who underwent sleeve gastrectomy from 2013 to 2015. Patients with previous bariatric procedures were excluded. Narrowing of a gastric sleeve includes: inability to pass a 9.6 mm gastroscope due to stenosis or sharp angulation or spiral hindering its passage.RESULTS Of 400 consecutive patients, 352 are included; the prevalence of dysphagia is 22.7%; 33 patients(9.3%) have narrowing of the sleeve with 25(7.1%) having sharp angulation or a spiral while 8(2.3%) have a stenosis. All 33 patients underwent balloon dilatation of the gastric sleeve and dysphagia resolved in 13 patients(39%); 10 patients(30%) noted resolution of dysphagia after two additional dilatations. In a multivariate model, medical conditions associated with post-operative dysphagia include diabetes mellitus, symptoms of esophageal reflux, a low whole blood thiamine level, hypothyroidism, use of non-steroidal anti-inflammatory drugs, and use of opioids.CONCLUSION Narrowing of the gastric sleeve and gastric sleeve stenosis are common after VSG. Endoscopic balloon dilatations of the gastric sleeve resolves dysphagia in 69% of patients.Anand Nath Sayali Yewale Tung Tran John S Brebbia Timothy R Shope Timothy R Koch 2016World Journal of Gastroenterology2016,22,47:3
3Organization of future training in bariatric gastroenterology显示文摘A world-wide rise in the prevalence of obesity continues. This rise increases the occurrence of, risks of, and costs of treating obesity-related medical conditions. Diet and activity programs are largely inadequate for the long-term treatment of medically-complicated obesity. Physicians who deliver gastrointestinal care after completing traditional training programs, including gastroenterologists and general surgeons, are not uniformly trained in or familiar with available bariatric care. It is certain that gastrointestinal physicians will incorporate new endoscopic methods into their practice for the treatment of individuals with medically-complicated obesity, although the longterm impact of these endoscopic techniques remains under investigation. It is presently unclear whether gastrointestinal physicians will be able to provide or coordinate important allied services in bariatric surgery, endocrinology, nutrition, psychological evaluation and support, and social work. Obtaining longitudinal results examining the effectiveness of this ad hoc approach will likely be difficult, based on prior experience with other endoscopic measures, such as the adenoma detection rates from screening colonoscopy. As a longterm approach, development of a specific curriculum incorporating one year of subspecialty training in bariatrics to the present training of gastrointestinal fellows needs to be reconsidered. This approach should be facilitated by gastrointestinal trainees' prior residency training in subspecialties that provide care for individuals with medical complications of obesity, including endocrinology, cardiology, nephrology, and neurology. Such training could incorporate additional rotations with collaborating providers in bariatric surgery, nutrition, and psychiatry. Since such training would be provided in accredited programs, longitudinal studies could be developed to examine the potential impact on accepted measures of care, such as complication rates, outcomes, and costs, in individuals with medically-complicated obesity.Timothy R Koch Timothy R Shope Christopher J Gostout 2017World Journal of Gastroenterology2017,23,35:2
4The influence of film crystallinity on the coupling efficiency of ZnO optical modulator waveguides显示文摘Koch M H Timbrell P Y Lamb R N 1995Semicond Sci Technol1995,10,:2
5The intrinsic stress of polycrystalline and epitaxial thin metal films显示文摘Koch R 1994Phys :Condensed Mater1994,6,:2
6Current and future impact of clinical gastrointestinal research on patient care in diabetes mellitus显示文摘The worldwide rise in the prevalence of obesity supports the need for an increased interaction between ongoing clinical research in the allied fields of gastrointestinal medicine/surgery and diabetes mellitus. There have been a number of clinically-relevant advances in diabetes, obesity, and metabolic syndrome emanating from gastroenterological research. Gastric emptying is a significant factor in the development of upper gastrointestinal symptoms. However, it is not the only mechanism whereby such symptoms occur in patients with diabetes. Disorders of intrinsic pacing are involved in the control of stomach motility in patients with gastroparesis; on the other hand, there is limited impact of glycemic control on gastric emptying in patients with established diabetic gastroparesis. Upper gastrointestinal functions related to emptying and satiations are significantly associated with weight gain in obesity. Medications used in the treatment of diabetes or metabolic syndrome, particularly those related to pancreatic hormones and incretins affect upper gastrointestinal tract function and reduce hyperglycemia and facilitate weight loss. The degree of gastric emptying delay is significantly correlated with the weight loss in response to liraglutide, a glucagonlike peptide-1 analog. Network meta-analysis shows that liraglutide is one of the two most efficacious medical treatments of obesity, the other being the combination treatment phentermine-topiramate. Interventional therapies for the joint management of obesity and diabetes mellitus include newer endoscopic procedures, which require long-term follow-up and bariatric surgical procedure for which long-term follow up shows advantages for individuals with diabetes. Newer bariatric procedures are presently undergoing clinical evaluation. On the horizon, combination therapies, in part directed at gastrointestinal functions, appear promising for these indications. Ongoing and future gastroenterological research when translated to care of individuals with diabetes mellitus should provide additional options to improve their clinical outcomes.Timothy R Koch Timothy R Shope Michael Camilleri 2018World Journal of Diabetes2018,9,11:2
7Ductility of plain and confined concrete under different strain rates显示文摘Dilger W H Koch T Kowalzyk R 1984ACI J1984,81,1:1
8Experience and attitudes towards CAM-a survey of internal and psychosomatic patients in a German university hospital显示文摘HUBER R KOCH D BEISER I 2004Altern Ther Health M2004,10,:1
9The transcription fac- tor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation 显示文摘Koch M A Tucker-Heard G Perdue N R 2009Nat Immunol2009,10,6:1
10The role of SO2 as an additive to organic Li-ion battery electrolytes显示文摘Ein-Eli Y Thomas S R Koch V R 1997J Electrochem Soc1997,144,4:1
11Clinical pathways : effects on professional practice, patient outcomes, length of stay and hospital costs显示文摘Rotter T Koch R Kugler J 2007Cochrane Database Syst Rev2007,17,3:1
12Pharmacokinetics and im bioavailability of ceftiofur in Asian elephants (Elephas maximus) 显示文摘Dumonceaux G Isaza R Koch D E 2005Journal of Veterinary Pharmacology and Therapeutics2005,28,3:1
13Evaluation of chronic gastrointesti- nal symptoms following Persian Gulf War exposure 显示文摘Koch T R Emory T S 2005Mil Med2005,170,8:1
14Chemical oxidation: A route to en- hanced capacity in Li-ion graphite anodes显示文摘Ein-Eli Y Koch V R 1997J Electrochem Soe1997,144,9:1
15Sugar levels modulate differential expression of maize sucrose synthase genes显示文摘Koch K E Nolte K D Duke E R 1992Plant Cell1992,,4:1
16Economic feasibility of variable-rate nitrogen application utilizing site-specific management zones 显示文摘Koch B Khosla R Frasier W M 2004Agronomy Journal2004,96,6:1
17Biological monitoring of the five major metabohies of di - (2 - ethylhexyl) phthalate (DEHP) in hu- man urine using column - switching liquid chromatography - tandem mass spectrometry显示文摘Preuss R Koch HM Angerer J 2005J Chromatogr B Anlyt Technol Biomed Life Sci2005,816,12:1
18Studies on copper release from copper-T device (T-Cu200)and its influence on sperm migration in vitro显示文摘Zielske H Koch UJ Badura R 1974Contraception1974,10,:1
19Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis 显示文摘Haubitz M Koch KM Brunkhorst R 1998Nephrol Dial Transplant1998,13,8:1
20The Measurement of Observer Agreement for Gategorical data显示文摘Landis J R Koch G G 1977Bio metrics1977,33,:1
返回顶部 每页显示:
共70页 首页 上一页 第1页 下一页 末页 /70 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费